Cerebrospinal fluid purification system

    公开(公告)号:US11040179B2

    公开(公告)日:2021-06-22

    申请号:US16548554

    申请日:2019-08-22

    IPC分类号: A61M1/36 A61M25/00 A61M27/00

    摘要: The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a catheter flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.

    Cerebrospinal fluid purification system

    公开(公告)号:US11065425B2

    公开(公告)日:2021-07-20

    申请号:US16548554

    申请日:2019-08-22

    IPC分类号: A61M1/36 A61M25/00 A61M27/00

    摘要: The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a catheter flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.

    Cerebrospinal fluid purification system

    公开(公告)号:US10398884B2

    公开(公告)日:2019-09-03

    申请号:US15410219

    申请日:2017-01-19

    IPC分类号: A61M1/36 A61M25/00 A61M27/00

    摘要: The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a catheter flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.